Skip to main content

Find Clinical Trials

Home
Conditions
Malignant Paraganglioma

Clinical trial condition

Malignant Paraganglioma

Explore clinical trials studying Malignant Paraganglioma. Study availability and eligibility vary by location and protocol.

4 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Malignant Paraganglioma trial results

Completed

The Efficacy and Safety of Anlotinib in Patients With Metastatic Pheochromocytoma or Paraganglioma

NCT04860700

Conditions: Malignant Adrenal Gland Pheochromocytoma, Malignant Paraganglioma, Neoplasm Metastasis, +14 more
Locations: Peking Union Medical College Hospital Beijing, Beijing Municipality, China

View Trial Details

Completed

Effect of Cabozantinib S-Malate or Lenvatinib Mesylate on Weight and Body Composition in Patients With Metastatic Endocrine Cancer

NCT02592356

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +15 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Lenvatinib in Treating Patients With Metastatic or Advanced Pheochromocytoma or Paraganglioma That Cannot Be Removed by Surgery

NCT03008369

Conditions: Malignant Adrenal Gland Pheochromocytoma, Malignant Paraganglioma, Metastatic Adrenal Gland Pheochromocytoma, +9 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors

NCT01155258

Conditions: Adenocarcinoma, Adnexal Diseases, Breast Diseases, +115 more
Locations: USC/Norris Comprehensive Cancer Center Los Angeles, California, United States

View Trial Details